Consumers hoping a couple of recent policy proposals might lower prices for their prescription drugs may be out of luck, at least for now. Earlier this year the Trump administration had proposed a...

Is the U.S. ready for a discussion about paying for caregiving, an increasingly vexing and costly problem for a growing number of Americans? The answer may be “yes.” It has become obvious that...

The Food and Drug Administration just announced it would once again try to regulate tobacco products. This time the target of the agency’s regulatory hand is what it believes is the growing menace...

A new health insurance option awaits consumers this fall. Proponents say it will offer lower premiums and relief from increasingly expensive Obamacare policies sold in the so-called individual...

Recently I heard from a woman in rural Nebraska who told me about her 76-year old father, who in late April had a lemon-size cancerous mass removed from his brain. The man chose to have his...

Recently a tweet from Lauren Sausser, a fine health reporter I know in South Carolina, caught my eye. “Crazy drug prices became personal. My dad will start Keytruda regimen on Friday, $15,000 per...

Earlier this year an Illinois woman sent an email telling me of the poor care her husband received at a large Chicago hospital. After six weeks of fighting for his life, he died. “I wish you could...

This fall, the House of Representatives is likely to take up legislation passed by the Senate that gives terminally ill patients the right to try unproven, experimental drugs that are not yet on...

As Obamacare approaches its fifth sign-up season, policyholders in many parts of the country are facing a marketplace with fewer choices and higher premiums. A New York Times analysis has found...

Recently I heard from a woman in rural Nebraska who told me about her 76-year old father, who in late April had a lemon-size cancerous mass removed from his brain. The man chose to have his...